Vitamin Shoppe, Inc (NYSE:VSI) has earned a consensus recommendation of “Hold” from the eleven brokerages that are presently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating and eight have given a hold rating to the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $13.83.

VSI has been the topic of several research reports. Zacks Investment Research lowered shares of Vitamin Shoppe from a “hold” rating to a “strong sell” rating in a research note on Saturday, May 13th. Morgan Stanley upgraded shares of Vitamin Shoppe from an “underweight” rating to an “equal weight” rating and set a $14.00 price objective on the stock in a research note on Thursday, May 11th. Barclays PLC reiterated an “equal weight” rating and issued a $13.00 price objective (down previously from $24.00) on shares of Vitamin Shoppe in a research note on Sunday, May 14th. Gabelli lowered shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a research note on Thursday, May 11th. Finally, ValuEngine lowered shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd.

Shares of Vitamin Shoppe (NYSE VSI) traded up 3.33% during mid-day trading on Friday, hitting $6.20. 1,289,284 shares of the stock traded hands. The stock has a 50-day moving average of $10.58 and a 200-day moving average of $16.02. The company’s market cap is $144.03 million. Vitamin Shoppe has a 52 week low of $5.75 and a 52 week high of $28.56.

Vitamin Shoppe (NYSE:VSI) last released its quarterly earnings data on Wednesday, August 9th. The specialty retailer reported $0.23 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.39 by $0.16. The company had revenue of $304.84 million during the quarter, compared to analyst estimates of $314.74 million. Vitamin Shoppe had a negative net margin of 11.98% and a positive return on equity of 8.33%. The firm’s quarterly revenue was down 8.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.55 EPS. Analysts anticipate that Vitamin Shoppe will post $0.98 EPS for the current year.

Several hedge funds and other institutional investors have recently made changes to their positions in VSI. Comerica Bank raised its position in shares of Vitamin Shoppe by 37.8% in the first quarter. Comerica Bank now owns 35,339 shares of the specialty retailer’s stock valued at $689,000 after buying an additional 9,685 shares during the period. Norges Bank purchased a new position in Vitamin Shoppe during the fourth quarter worth about $6,444,000. First Trust Advisors LP purchased a new position in Vitamin Shoppe during the first quarter worth about $549,000. LSV Asset Management raised its position in Vitamin Shoppe by 109.4% in the first quarter. LSV Asset Management now owns 76,648 shares of the specialty retailer’s stock worth $1,544,000 after buying an additional 40,048 shares during the last quarter. Finally, Principal Financial Group Inc. raised its position in Vitamin Shoppe by 3.7% in the first quarter. Principal Financial Group Inc. now owns 181,564 shares of the specialty retailer’s stock worth $3,659,000 after buying an additional 6,408 shares during the last quarter.

TRADEMARK VIOLATION WARNING: “Vitamin Shoppe, Inc (VSI) Receives Consensus Recommendation of “Hold” from Analysts” was first posted by Watch List News and is owned by of Watch List News. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of US and international copyright & trademark laws. The legal version of this piece can be accessed at https://www.watchlistnews.com/vitamin-shoppe-inc-vsi-receives-consensus-recommendation-of-hold-from-analysts/1474940.html.

About Vitamin Shoppe

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Analyst Recommendations for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.